Zobrazeno 1 - 10
of 561
pro vyhledávání: '"Chandana SR"'
Autor:
Kulkarni HR; BAMF Health, Grand Rapids, Michigan; harshad.kulkarni@bamfhealth.com.; Department of Radiology, Michigan State University College of Human Medicine, East Lansing, Michigan., Maupin KA; BAMF Health, Grand Rapids, Michigan.; Department of Radiology, Michigan State University College of Human Medicine, East Lansing, Michigan., Brennan T; BAMF Health, Grand Rapids, Michigan., Forsberg J; BAMF Health, Grand Rapids, Michigan.; Department of Radiology, Michigan State University College of Human Medicine, East Lansing, Michigan., Rogers D; BAMF Health, Grand Rapids, Michigan., Olson M; BAMF Health, Grand Rapids, Michigan., Mancini BR; BAMF Health, Grand Rapids, Michigan.; Department of Radiology, Michigan State University College of Human Medicine, East Lansing, Michigan., Chang A; BAMF Health, Grand Rapids, Michigan., Chandana SR; The Cancer & Hematology Centers, Grand Rapids, Michigan; and., Kobayashi R; Nihon Medi-Physics Co., Ltd., Tokyo, Japan.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Nov 01; Vol. 65 (11), pp. 1815. Date of Electronic Publication: 2024 Nov 01.
Autor:
Botta GP; Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA 92037, United States., Abdelrahim M; Section of GI Oncology, Department of Medical Oncology, Houston Methodist Cancer Center, Houston, TX 77030, United States., Drengler RL; Medical Oncology, The START Center for Cancer Care, San Antonio, TX 78229, United States., Aushev VN; Oncology, Natera, Inc., Austin, TX 78753, United States., Esmail A; Section of GI Oncology, Department of Medical Oncology, Houston Methodist Cancer Center, Houston, TX 77030, United States., Laliotis G; Oncology, Natera, Inc., Austin, TX 78753, United States., Brewer CM; Oncology, Natera, Inc., Austin, TX 78753, United States., George GV; Oncology, Natera, Inc., Austin, TX 78753, United States., Abbate SM; Medical Oncology, The START Center for Cancer Care, San Antonio, TX 78229, United States., Chandana SR; Department of Gastrointestinal Medical Oncology, Cancer & Hematology Centers of Western Michigan, Grand Rapids, MI 49546, United States., Tejani MA; Hematology and Oncology, Advent Health Cancer Institute, Orlando, FL 32804, United States., Malla M; Section of Hematology and Oncology, University of Alabama at Birmingham, AL 35233,United States., Bansal D; Department of Hematology-Oncology, Saint Luke's Cancer Institute, Kansas City, MO 64111, United States., Rivero-Hinojosa S; Oncology, Natera, Inc., Austin, TX 78753, United States., Spickard E; Oncology, Natera, Inc., Austin, TX 78753, United States., McCormick N; Oncology, Natera, Inc., Austin, TX 78753, United States., Cecchini M; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT 06520, United States., Lacy J; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT 06520, United States., Fei N; Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, United States., Kasi PM; Division of Internal Medicine, Department of Oncology/Hematology, Weill Cornell Medicine, New York, NY 10021, United States., Kasi A; Division of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Kansas City, KS 66160, United States., Dayyani F; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA 92868, United States., Hanna DL; Division of Medical Oncology, Norris Cancer Center, Keck Medicine of USC, Los Angeles, CA 90033, United States., Sharma S; Oncology, Natera, Inc., Austin, TX 78753, United States., Malhotra M; Oncology, Natera, Inc., Austin, TX 78753, United States., Aleshin A; Oncology, Natera, Inc., Austin, TX 78753, United States., Liu MC; Oncology, Natera, Inc., Austin, TX 78753, United States., Jurdi A; Oncology, Natera, Inc., Austin, TX 78753, United States.
Publikováno v:
The oncologist [Oncologist] 2024 Oct 03; Vol. 29 (10), pp. 859-869.
Autor:
Chandana SR; Department of Gastrointestinal Medical Oncology, The Cancer and Hematology Centers, Grand Rapids, MI, USA. Electronic address: schandana@chcwm.com., Woods LM; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK., Maxwell F; Ipsen, Slough, UK., Gandolfo R; Oxford PharmaGenesis, Oxford, UK., Bekaii-Saab T; Department of Internal Medicine, Mayo Clinic, Phoenix, AZ, USA.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Apr; Vol. 201, pp. 113941. Date of Electronic Publication: 2024 Mar 02.
Autor:
Chandana SR; The Cancer and Hematology Centers, Grand Rapids, MI, USA.; Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, MI, USA., Frisch A; College of Human Medicine, Michigan State University, Grand Rapids, MI, USA., Mendoza S; College of Human Medicine, Michigan State University, Grand Rapids, MI, USA., Sinniah RS; College of Human Medicine, Michigan State University, Grand Rapids, MI, USA., Crysler O; Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA., Banga R; Renal Associates of West Michigan, Grand Rapids, MI, USA., Perkins DE; Department of Pathology, Spectrum Health, Grand Rapids, MI, USA.
Publikováno v:
Journal of gastrointestinal oncology [J Gastrointest Oncol] 2024 Feb 29; Vol. 15 (1), pp. 478-484. Date of Electronic Publication: 2024 Feb 01.
Autor:
Chandana SR; Department of Gastrointestinal Medical Oncology, The Cancer and Hematology Centers, Grand Rapids, MI, USA. Electronic address: schandana@chcwm.com., Woods LM; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK., Maxwell F; Ipsen, Slough, UK., Gandolfo R; Oxford PharmaGenesis, Oxford, UK., Bekaii-Saab T; Department of Internal Medicine, Mayo Clinic, Phoenix, AZ, USA.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Feb; Vol. 198, pp. 113471. Date of Electronic Publication: 2023 Dec 12.
Autor:
Wainberg ZA; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: zwainberg@mednet.ucla.edu., Melisi D; Università degli studi di Verona and Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy., Macarulla T; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Pazo Cid R; Hospital Universitario Miguel Servet, Zaragoza, Spain., Chandana SR; Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI, USA., De La Fouchardière C; Centre Léon Bérard, Lyon, France., Dean A; St John of God Subiaco Hospital, Subiaco, WA, Australia., Kiss I; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Lee WJ; National Cancer Center, Goyang, South Korea., Goetze TO; Krankenhaus Nordwest, Frankfurt am Main, Germany., Van Cutsem E; University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium., Paulson AS; Texas Oncology-Baylor Charles A Sammons Cancer Center, Dallas, TX, USA., Bekaii-Saab T; Mayo Clinic, Scottsdale, AZ, USA., Pant S; MD Anderson Cancer Center, Houston, TX, USA., Hubner RA; The Christie NHS Foundation Trust, and Division of Cancer Sciences, University of Manchester, Manchester, UK., Xiao Z; Ipsen, Cambridge, MA, USA., Chen H; Ipsen, Cambridge, MA, USA., Benzaghou F; Ipsen, Cambridge, MA, USA., O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Lancet (London, England) [Lancet] 2023 Oct 07; Vol. 402 (10409), pp. 1272-1281. Date of Electronic Publication: 2023 Sep 11.
Autor:
McLouth LE; Department of Behavioral Science, College of Medicine, Markey Cancer Center, University of Kentucky, 467 Healthy Kentucky Research Building, 760 Press Avenue, Lexington, KY, 40508, USA. Laurie.mclouth@uky.edu., Zheng Y; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Smith S; Nancy N. and J.C. Lewis Cancer and Research Pavilion, St. Joseph's/Candler, Savannah, GA, USA., Hodi FS; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA, USA.; Dana-Farber Cancer Institute/Harvard Cancer Center, Boston, MA, USA., Rao UN; University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Cohen GI; Greater Baltimore Medical Center, Baltimore, MD, USA., Amatruda TT; Minnesota Oncology, Fridley, MN, USA., Dakhil SR; Ascension Via Christi Hospitals, Wichita, KS, USA., Curti BD; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Nakhoul I; Regional Cancer Center at Indian Path Community Hospital, Kingsport, TN, USA., Chandana SR; Cancer and Hematology Centers of Western Michigan/Cancer Research Consortium of West Michigan NCORP, Grand Rapids, MI, USA., Bane CL; Good Samaritan Hospital-Dayton, Dayton, OH, USA., Marinier DE; Gundersen Health System, La Crosse, WI, USA., Lee SJ; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Sondak VK; Moffitt Cancer Center, Tampa, FL, USA., Kirkwood JM; University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Tarhini AA; Moffitt Cancer Center, Tampa, FL, USA., Wagner LI; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 Jan; Vol. 32 (1), pp. 183-196. Date of Electronic Publication: 2022 Aug 27.
Autor:
Sardar M; Division of Hematology-Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, Az, USA., Recio-Boiles A; Division of Hematology-Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, Az, USA., Mody K; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Cancer Center, Jacksonville, FL, USA., Karime C; Department of Medicine, Mayo Clinic, Jacksonville, FL, USA., Chandana SR; Department of Medicine, Michigan State University, MI, USA., Mahadevan D; Division of Hematology and Oncology, Department of Medicine, University of Texas, San Antonio, Texas, USA., Starr J; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Cancer Center, Jacksonville, FL, USA., Jones J; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Cancer Center, Jacksonville, FL, USA., Borad M; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Cancer Center, Phoenix, AZ, USA., Babiker H; Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Cancer Center, Jacksonville, FL, USA.
Publikováno v:
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2022 Dec; Vol. 23 (18), pp. 2079-2089. Date of Electronic Publication: 2022 Nov 28.
Autor:
Shankaran V; Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA, USA., Unger JM; SWOG Statistics and Data Management Center, Seattle, WA, USA., Darke AK; SWOG Statistics and Data Management Center, Seattle, WA, USA., Suga JM; Kaiser Permanente-Vallejo/Kaiser Permanente NCORP, Vallejo, CA, USA., Wade JL; Cancer Care Specialists of Illinois/Heartland NCORP, Decatur, IL, USA., Kourlas PJ; Columbus Oncology Associates, Columbus/Columbus NCORP, Columbus, OH, USA., Chandana SR; Cancer and Hematology Centers of Western Michigan/Cancer Research Consortium of West Michigan NCORP, Grand Rapids, MI, USA., O'Rourke MA; Prisma Health Cancer Institute/NCORP of the Carolinas (Prisma Health), Greenville, SC, USA., Satti S; Ochsner Cancer Institute, New Orleans, LA, USA., Liggett D; SWOG Data Operations Center/Cancer Research and Biostatistics (CRAB), Seattle, WA, USA., Hershman DL; Columbia University, New York, NY, USA., Ramsey SD; Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2022 Mar 08; Vol. 114 (3), pp. 372-380.
Autor:
Karime C; Department of Medicine, Mayo Clinic, Jacksonville, FL, USA., Wang J; Department of Medicine, Mayo Clinic, Jacksonville, FL, USA., Woodhead G; Department of Medical Imaging, University of Arizona Collage of Medicine, Tucson, AZ, USA., Mody K; Department of Medicine, Division of Hematology Oncology, Mayo Clinic, Jacksonville, FL, USA., Hennemeyer CT; Department of Medical Imaging, University of Arizona Collage of Medicine, Tucson, AZ, USA., Borad MJ; Department of Medicine, Division of Hematology Oncology, Mayo Clinic, Phoenix, AZ, USA., Mahadevan D; Division of Hematology and Oncology, University of Texas Health San Antonio, TX, USA., Chandana SR; Department of Medicine, Michigan State University, East Lansing, MI, USA.; Phase I Program, Start Midwest, Grand Rapids, MI, USA., Babiker H; Department of Medicine, Division of Hematology Oncology, Mayo Clinic, Jacksonville, FL, USA.
Publikováno v:
Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2022 Jan; Vol. 31 (1), pp. 1-13. Date of Electronic Publication: 2021 Dec 28.